BURCON NUTRASCIENCE CORP (BU.CA) Fundamental Analysis & Valuation

TSX:BU • CA1208313009

Current stock price

1.9 CAD
+0.01 (+0.53%)
Last:

This BU.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BU.CA Profitability Analysis

1.1 Basic Checks

  • BU had negative earnings in the past year.
  • BU had a negative operating cash flow in the past year.
  • In the past 5 years BU always reported negative net income.
  • BU had a negative operating cash flow in each of the past 5 years.
BU.CA Yearly Net Income VS EBIT VS OCF VS FCFBU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M -25M

1.2 Ratios

  • With a Return On Assets value of -53.81%, BU is not doing good in the industry: 74.07% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -53.81%
ROE N/A
ROIC N/A
ROA(3y)-113.59%
ROA(5y)-75.48%
ROE(3y)-292.02%
ROE(5y)-182.82%
ROIC(3y)N/A
ROIC(5y)N/A
BU.CA Yearly ROA, ROE, ROICBU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 400 -400 -600

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for BU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BU.CA Yearly Profit, Operating, Gross MarginsBU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5K -10K -15K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. BU.CA Health Analysis

2.1 Basic Checks

  • BU does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • BU has more shares outstanding than it did 1 year ago.
  • BU has more shares outstanding than it did 5 years ago.
  • BU has a worse debt/assets ratio than last year.
BU.CA Yearly Shares OutstandingBU.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
BU.CA Yearly Total Debt VS Total AssetsBU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of -9.97, we must say that BU is in the distress zone and has some risk of bankruptcy.
  • BU has a worse Altman-Z score (-9.97) than 70.37% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -9.97
ROIC/WACCN/A
WACC9.39%
BU.CA Yearly LT Debt VS Equity VS FCFBU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 0.22 indicates that BU may have some problems paying its short term obligations.
  • BU's Current ratio of 0.22 is on the low side compared to the rest of the industry. BU is outperformed by 77.78% of its industry peers.
  • A Quick Ratio of 0.15 indicates that BU may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.15, BU is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.15
BU.CA Yearly Current Assets VS Current LiabilitesBU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. BU.CA Growth Analysis

3.1 Past

  • BU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -89.90%.
  • BU shows a strong growth in Revenue. In the last year, the Revenue has grown by 337.48%.
  • Measured over the past years, BU shows a very strong growth in Revenue. The Revenue has been growing by 66.28% on average per year.
EPS 1Y (TTM)-89.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
Revenue 1Y (TTM)337.48%
Revenue growth 3Y30.91%
Revenue growth 5Y66.28%
Sales Q2Q%1131.83%

3.2 Future

  • BU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.82% yearly.
  • BU is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 228.16% yearly.
EPS Next Y90.69%
EPS Next 2Y42.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year146.15%
Revenue Next 2Y228.17%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BU.CA Yearly Revenue VS EstimatesBU.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M
BU.CA Yearly EPS VS EstimatesBU.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

2

4. BU.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • BU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 61.49, BU can be considered very expensive at the moment.
  • 70.37% of the companies in the same industry are more expensive than BU, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, BU is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 61.49
BU.CA Price Earnings VS Forward Price EarningsBU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BU.CA Per share dataBU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

  • BU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BU's earnings are expected to grow with 42.82% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.82%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BU.CA Dividend Analysis

5.1 Amount

  • BU does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BU.CA Fundamentals: All Metrics, Ratios and Statistics

BURCON NUTRASCIENCE CORP

TSX:BU (3/27/2026, 7:00:00 PM)

1.9

+0.01 (+0.53%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-11
Earnings (Next)06-22
Inst Owners5.83%
Inst Owner ChangeN/A
Ins Owners31.02%
Ins Owner ChangeN/A
Market Cap24.11M
Revenue(TTM)1.48M
Net Income(TTM)-12.90M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-511.65%
Min EPS beat(2)-579.61%
Max EPS beat(2)-443.69%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-29.44%
Min Revenue beat(2)-30.64%
Max Revenue beat(2)-28.24%
Revenue beat(4)1
Avg Revenue beat(4)-22.06%
Min Revenue beat(4)-95.36%
Max Revenue beat(4)66.02%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-900%
EPS NY rev (1m)98.97%
EPS NY rev (3m)98.97%
Revenue NQ rev (1m)-6.67%
Revenue NQ rev (3m)-6.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 61.49
P/S 16.28
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.06
EYN/A
EPS(NY)0.03
Fwd EY1.63%
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS0.12
BVpS-0.2
TBVpS-0.29
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -53.81%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-113.59%
ROA(5y)-75.48%
ROE(3y)-292.02%
ROE(5y)-182.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 54.43%
Cap/Sales 59.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.15
Altman-Z -9.97
F-Score5
WACC9.39%
ROIC/WACCN/A
Cap/Depr(3y)68.17%
Cap/Depr(5y)195.49%
Cap/Sales(3y)82.83%
Cap/Sales(5y)124.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
EPS Next Y90.69%
EPS Next 2Y42.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)337.48%
Revenue growth 3Y30.91%
Revenue growth 5Y66.28%
Sales Q2Q%1131.83%
Revenue Next Year146.15%
Revenue Next 2Y228.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8.7%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-56.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-43.13%
OCF growth 3YN/A
OCF growth 5YN/A

BURCON NUTRASCIENCE CORP / BU.CA Fundamental Analysis FAQ

What is the fundamental rating for BU stock?

ChartMill assigns a fundamental rating of 2 / 10 to BU.CA.


What is the valuation status for BU stock?

ChartMill assigns a valuation rating of 2 / 10 to BURCON NUTRASCIENCE CORP (BU.CA). This can be considered as Overvalued.


What is the profitability of BU stock?

BURCON NUTRASCIENCE CORP (BU.CA) has a profitability rating of 0 / 10.


What is the expected EPS growth for BURCON NUTRASCIENCE CORP (BU.CA) stock?

The Earnings per Share (EPS) of BURCON NUTRASCIENCE CORP (BU.CA) is expected to grow by 90.69% in the next year.